Declining Risk of Sudden Death in Heart Failure
Data were analyzed from 40,195 patients with heart failure with reduced ejection fraction enrolled in 12 clinical trials in the 1995–2014 period. Sudden-death rates declined substantially over time, a finding consistent with a cumulative effect of evidence-based medical therapy.
Saved in:
| Published in: | The New England journal of medicine Vol. 377; no. 1; pp. 41 - 51 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
Massachusetts Medical Society
06.07.2017
|
| Subjects: | |
| ISSN: | 0028-4793, 1533-4406, 1533-4406 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Data were analyzed from 40,195 patients with heart failure with reduced ejection fraction enrolled in 12 clinical trials in the 1995–2014 period. Sudden-death rates declined substantially over time, a finding consistent with a cumulative effect of evidence-based medical therapy. |
|---|---|
| AbstractList | The risk of sudden death has changed over time among patients with symptomatic heart failure and reduced ejection fraction with the sequential introduction of medications including angiotensin-converting-enzyme inhibitors, angiotensin-receptor blockers, beta-blockers, and mineralocorticoid-receptor antagonists. We sought to examine this trend in detail.BACKGROUNDThe risk of sudden death has changed over time among patients with symptomatic heart failure and reduced ejection fraction with the sequential introduction of medications including angiotensin-converting-enzyme inhibitors, angiotensin-receptor blockers, beta-blockers, and mineralocorticoid-receptor antagonists. We sought to examine this trend in detail.We analyzed data from 40,195 patients who had heart failure with reduced ejection fraction and were enrolled in any of 12 clinical trials spanning the period from 1995 through 2014. Patients who had an implantable cardioverter-defibrillator at the time of trial enrollment were excluded. Weighted multivariable regression was used to examine trends in rates of sudden death over time. Adjusted hazard ratios for sudden death in each trial group were calculated with the use of Cox regression models. The cumulative incidence rates of sudden death were assessed at different time points after randomization and according to the length of time between the diagnosis of heart failure and randomization.METHODSWe analyzed data from 40,195 patients who had heart failure with reduced ejection fraction and were enrolled in any of 12 clinical trials spanning the period from 1995 through 2014. Patients who had an implantable cardioverter-defibrillator at the time of trial enrollment were excluded. Weighted multivariable regression was used to examine trends in rates of sudden death over time. Adjusted hazard ratios for sudden death in each trial group were calculated with the use of Cox regression models. The cumulative incidence rates of sudden death were assessed at different time points after randomization and according to the length of time between the diagnosis of heart failure and randomization.Sudden death was reported in 3583 patients. Such patients were older and were more often male, with an ischemic cause of heart failure and worse cardiac function, than those in whom sudden death did not occur. There was a 44% decline in the rate of sudden death across the trials (P=0.03). The cumulative incidence of sudden death at 90 days after randomization was 2.4% in the earliest trial and 1.0% in the most recent trial. The rate of sudden death was not higher among patients with a recent diagnosis of heart failure than among those with a longer-standing diagnosis.RESULTSSudden death was reported in 3583 patients. Such patients were older and were more often male, with an ischemic cause of heart failure and worse cardiac function, than those in whom sudden death did not occur. There was a 44% decline in the rate of sudden death across the trials (P=0.03). The cumulative incidence of sudden death at 90 days after randomization was 2.4% in the earliest trial and 1.0% in the most recent trial. The rate of sudden death was not higher among patients with a recent diagnosis of heart failure than among those with a longer-standing diagnosis.Rates of sudden death declined substantially over time among ambulatory patients with heart failure with reduced ejection fraction who were enrolled in clinical trials, a finding that is consistent with a cumulative benefit of evidence-based medications on this cause of death. (Funded by the China Scholarship Council and the University of Glasgow.).CONCLUSIONSRates of sudden death declined substantially over time among ambulatory patients with heart failure with reduced ejection fraction who were enrolled in clinical trials, a finding that is consistent with a cumulative benefit of evidence-based medications on this cause of death. (Funded by the China Scholarship Council and the University of Glasgow.). The risk of sudden death has changed over time among patients with symptomatic heart failure and reduced ejection fraction with the sequential introduction of medications including angiotensin-converting-enzyme inhibitors, angiotensin-receptor blockers, beta-blockers, and mineralocorticoid-receptor antagonists. We sought to examine this trend in detail. We analyzed data from 40,195 patients who had heart failure with reduced ejection fraction and were enrolled in any of 12 clinical trials spanning the period from 1995 through 2014. Patients who had an implantable cardioverter-defibrillator at the time of trial enrollment were excluded. Weighted multivariable regression was used to examine trends in rates of sudden death over time. Adjusted hazard ratios for sudden death in each trial group were calculated with the use of Cox regression models. The cumulative incidence rates of sudden death were assessed at different time points after randomization and according to the length of time between the diagnosis of heart failure and randomization. Sudden death was reported in 3583 patients. Such patients were older and were more often male, with an ischemic cause of heart failure and worse cardiac function, than those in whom sudden death did not occur. There was a 44% decline in the rate of sudden death across the trials (P=0.03). The cumulative incidence of sudden death at 90 days after randomization was 2.4% in the earliest trial and 1.0% in the most recent trial. The rate of sudden death was not higher among patients with a recent diagnosis of heart failure than among those with a longer-standing diagnosis. Rates of sudden death declined substantially over time among ambulatory patients with heart failure with reduced ejection fraction who were enrolled in clinical trials, a finding that is consistent with a cumulative benefit of evidence-based medications on this cause of death. (Funded by the China Scholarship Council and the University of Glasgow.). BACKGROUND The risk of sudden death has changed over time among patients with symptomatic heart failure and reduced ejection fraction with the sequential introduction of medications including angiotensin-converting-enzyme inhibitors, angiotensin-receptor blockers, beta-blockers, and mineralocorticoid-receptor antagonists. We sought to examine this trend in detail. We analyzed data from 40,195 patients who had heart failure with reduced ejection fraction and were enrolled in any of 12 clinical trials spanning the period from 1995 through 2014. Patients who had an implantable cardioverter-defibrillator at the time of trial enrollment were excluded. Weighted multivariable regression was used to examine trends in rates of sudden death over time. Adjusted hazard ratios for sudden death in each trial group were calculated with the use of Cox regression models. The cumulative incidence rates of sudden death were assessed at different time points after randomization and according to the length of time between the diagnosis of heart failure and randomization. Sudden death was reported in 3583 patients. Such patients were older and were more often male, with an ischemic cause of heart failure and worse cardiac function, than those in whom sudden death did not occur. There was a 44% decline in the rate of sudden death across the trials (P = 0.03). The cumulative incidence of sudden death at 90 days after randomization was 2.4% in the earliest trial and 1.0% in the most recent trial. The rate of sudden death was not higher among patients with a recent diagnosis of heart failure than among those with a longer-standing diagnosis. Rates of sudden death declined substantially over time among ambulatory patients with heart failure with reduced ejection fraction who were enrolled in clinical trials, a finding that is consistent with a cumulative benefit of evidence-based medications on this cause of death. (Funded by the China Scholarship Council and the University of Glasgow.) BackgroundThe risk of sudden death has changed over time among patients with symptomatic heart failure and reduced ejection fraction with the sequential introduction of medications including angiotensin-converting–enzyme inhibitors, angiotensin-receptor blockers, beta-blockers, and mineralocorticoid-receptor antagonists. We sought to examine this trend in detail.MethodsWe analyzed data from 40,195 patients who had heart failure with reduced ejection fraction and were enrolled in any of 12 clinical trials spanning the period from 1995 through 2014. Patients who had an implantable cardioverter–defibrillator at the time of trial enrollment were excluded. Weighted multivariable regression was used to examine trends in rates of sudden death over time. Adjusted hazard ratios for sudden death in each trial group were calculated with the use of Cox regression models. The cumulative incidence rates of sudden death were assessed at different time points after randomization and according to the length of time between the diagnosis of heart failure and randomization.ResultsSudden death was reported in 3583 patients. Such patients were older and were more often male, with an ischemic cause of heart failure and worse cardiac function, than those in whom sudden death did not occur. There was a 44% decline in the rate of sudden death across the trials (P=0.03). The cumulative incidence of sudden death at 90 days after randomization was 2.4% in the earliest trial and 1.0% in the most recent trial. The rate of sudden death was not higher among patients with a recent diagnosis of heart failure than among those with a longer-standing diagnosis.ConclusionsRates of sudden death declined substantially over time among ambulatory patients with heart failure with reduced ejection fraction who were enrolled in clinical trials, a finding that is consistent with a cumulative benefit of evidence-based medications on this cause of death. (Funded by the China Scholarship Council and the University of Glasgow.) Data were analyzed from 40,195 patients with heart failure with reduced ejection fraction enrolled in 12 clinical trials in the 1995–2014 period. Sudden-death rates declined substantially over time, a finding consistent with a cumulative effect of evidence-based medical therapy. |
| Author | Barlera, Simona Swedberg, Karl Claggett, Brian L Latini, Roberto Jhund, Pardeep S Zannad, Faiez Shen, Li Maggioni, Aldo P Granger, Christopher B McMurray, John J.V Zile, Michael R Petrie, Mark C Dargie, Henry J Kjekshus, John Packer, Milton Wikstrand, John Solomon, Scott D Cleland, John G.F Køber, Lars Pitt, Bertram Tavazzi, Luigi |
| Author_xml | – sequence: 1 givenname: Li surname: Shen fullname: Shen, Li organization: From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) — all in the United Kingdom; the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico–Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) — all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d’Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.) – sequence: 2 givenname: Pardeep S surname: Jhund fullname: Jhund, Pardeep S organization: From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) — all in the United Kingdom; the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico–Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) — all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d’Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.) – sequence: 3 givenname: Mark C surname: Petrie fullname: Petrie, Mark C organization: From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) — all in the United Kingdom; the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico–Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) — all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d’Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.) – sequence: 4 givenname: Brian L surname: Claggett fullname: Claggett, Brian L organization: From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) — all in the United Kingdom; the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico–Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) — all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d’Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.) – sequence: 5 givenname: Simona surname: Barlera fullname: Barlera, Simona organization: From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) — all in the United Kingdom; the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico–Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) — all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d’Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.) – sequence: 6 givenname: John G.F surname: Cleland fullname: Cleland, John G.F organization: From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) — all in the United Kingdom; the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico–Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) — all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d’Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.) – sequence: 7 givenname: Henry J surname: Dargie fullname: Dargie, Henry J organization: From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) — all in the United Kingdom; the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico–Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) — all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d’Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.) – sequence: 8 givenname: Christopher B surname: Granger fullname: Granger, Christopher B organization: From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) — all in the United Kingdom; the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico–Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) — all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d’Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.) – sequence: 9 givenname: John surname: Kjekshus fullname: Kjekshus, John organization: From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) — all in the United Kingdom; the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico–Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) — all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d’Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.) – sequence: 10 givenname: Lars surname: Køber fullname: Køber, Lars organization: From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) — all in the United Kingdom; the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico–Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) — all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d’Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.) – sequence: 11 givenname: Roberto surname: Latini fullname: Latini, Roberto organization: From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) — all in the United Kingdom; the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico–Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) — all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d’Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.) – sequence: 12 givenname: Aldo P surname: Maggioni fullname: Maggioni, Aldo P organization: From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) — all in the United Kingdom; the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico–Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) — all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d’Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.) – sequence: 13 givenname: Milton surname: Packer fullname: Packer, Milton organization: From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) — all in the United Kingdom; the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico–Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) — all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d’Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.) – sequence: 14 givenname: Bertram surname: Pitt fullname: Pitt, Bertram organization: From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) — all in the United Kingdom; the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico–Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) — all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d’Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.) – sequence: 15 givenname: Scott D surname: Solomon fullname: Solomon, Scott D organization: From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) — all in the United Kingdom; the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico–Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) — all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d’Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.) – sequence: 16 givenname: Karl surname: Swedberg fullname: Swedberg, Karl organization: From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) — all in the United Kingdom; the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico–Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) — all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d’Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.) – sequence: 17 givenname: Luigi surname: Tavazzi fullname: Tavazzi, Luigi organization: From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) — all in the United Kingdom; the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico–Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) — all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d’Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.) – sequence: 18 givenname: John surname: Wikstrand fullname: Wikstrand, John organization: From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) — all in the United Kingdom; the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico–Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) — all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d’Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.) – sequence: 19 givenname: Faiez surname: Zannad fullname: Zannad, Faiez organization: From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) — all in the United Kingdom; the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico–Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) — all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d’Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.) – sequence: 20 givenname: Michael R surname: Zile fullname: Zile, Michael R organization: From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) — all in the United Kingdom; the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico–Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) — all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d’Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.) – sequence: 21 givenname: John J.V surname: McMurray fullname: McMurray, John J.V organization: From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) — all in the United Kingdom; the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico–Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) — all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d’Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.) |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28679089$$D View this record in MEDLINE/PubMed https://gup.ub.gu.se/publication/255565$$DView record from Swedish Publication Index (Göteborgs universitet) |
| BookMark | eNp10d1LHDEQAPBQlHqefexrWSgFX1aT3SSbPBb1qmIr-PEcspvZa667yZlsKP73jZ5aFMzDBMJvhszMLtpy3gFCnwk-IJjxw18n5z-9JhzLhokPaEZYXZeUYr6FZhhXoqSNrHfQbowrnA-h8iPaqQRvJBZyhg6PoRuss25ZXNn4p_B9cZ2MAVccg55-F9YVp6DDVCy0HVKAPbTd6yHCp6d7jm4XJzdHp-XF5Y-zo-8XZUcrMZVEcN7wXlCWQ22IgLatDQPcCqDccCr7tpetbLRmWBBNDKGGUpNRr6ts56jc1I1_YZ1atQ521OFeeW3VMq1VflomFUFVjDHOst_f-HXwdwnipEYbOxgG7cCnqIgkvMFSVDLTr2_oyqfgcjePimYneFZfnlRqRzAvH3geXQb1BnTBxxigV52d9GS9m0KelSJYPSxIvVrQ_75esp4Lv-e_bfw4RuVgNb7j_gEKTZqg |
| CitedBy_id | crossref_primary_10_1093_eurheartj_ehaa324 crossref_primary_10_1093_eurheartj_ehx782 crossref_primary_10_1111_jce_15670 crossref_primary_10_1016_j_hrthm_2024_10_078 crossref_primary_10_3390_jcm10081753 crossref_primary_10_1016_j_rec_2019_07_013 crossref_primary_10_1093_eurheartj_ehy876 crossref_primary_10_7759_cureus_38268 crossref_primary_10_1016_j_ijcard_2018_07_137 crossref_primary_10_1007_s10741_023_10326_1 crossref_primary_10_1002_ejhf_3731 crossref_primary_10_1038_s41569_020_0381_0 crossref_primary_10_1002_ejhf_1551 crossref_primary_10_1002_ejhf_3299 crossref_primary_10_1007_s00108_018_0493_3 crossref_primary_10_1016_j_jcmg_2019_11_013 crossref_primary_10_1007_s00392_021_01888_x crossref_primary_10_1007_s00399_020_00696_6 crossref_primary_10_1007_s11936_021_00954_x crossref_primary_10_1007_s11886_018_0974_y crossref_primary_10_1016_j_repce_2019_03_011 crossref_primary_10_1161_CIRCHEARTFAILURE_124_012447 crossref_primary_10_18087_cardio_2022_12_n2082 crossref_primary_10_1016_j_ijcard_2017_09_012 crossref_primary_10_1161_CIRCOUTCOMES_124_011349 crossref_primary_10_1093_eurheartj_ehac053 crossref_primary_10_1016_j_jacep_2022_12_025 crossref_primary_10_7326_L17_0691 crossref_primary_10_1002_ehf2_13414 crossref_primary_10_1007_s11897_021_00533_y crossref_primary_10_1007_s40266_018_0586_7 crossref_primary_10_1016_j_resuscitation_2019_01_010 crossref_primary_10_1002_ejhf_1541 crossref_primary_10_1016_j_hfc_2024_06_007 crossref_primary_10_1136_bmjopen_2018_023724 crossref_primary_10_1007_s12471_021_01555_w crossref_primary_10_2459_JCM_0000000000001085 crossref_primary_10_1161_CIRCHEARTFAILURE_117_004478 crossref_primary_10_3390_cells10113203 crossref_primary_10_1016_j_ijcard_2018_08_048 crossref_primary_10_1016_j_jacc_2017_07_735 crossref_primary_10_1002_ejhf_1306 crossref_primary_10_1016_j_jacc_2021_04_030 crossref_primary_10_1016_j_hrthm_2017_09_025 crossref_primary_10_1093_europace_euaf096 crossref_primary_10_1016_j_jchf_2019_05_013 crossref_primary_10_1111_jce_14006 crossref_primary_10_1002_ehf2_13506 crossref_primary_10_1002_ejhf_3150 crossref_primary_10_1093_eurheartj_ehae272 crossref_primary_10_1002_ejhf_1531 crossref_primary_10_15829_1560_4071_2020_4083 crossref_primary_10_3389_fcvm_2023_1078570 crossref_primary_10_1155_2018_5629342 crossref_primary_10_1161_CIRCEP_118_006452 crossref_primary_10_1016_j_cjca_2018_03_018 crossref_primary_10_2174_0113816128282062231218075341 crossref_primary_10_1002_ehf2_13062 crossref_primary_10_1161_CIRCEP_117_005888 crossref_primary_10_1007_s00392_019_01440_y crossref_primary_10_1016_j_jacc_2024_09_016 crossref_primary_10_1093_eurheartjsupp_suac087 crossref_primary_10_1111_jce_16654 crossref_primary_10_5507_bp_2021_015 crossref_primary_10_1161_CIRCRESAHA_117_312359 crossref_primary_10_1016_j_ijcard_2020_02_025 crossref_primary_10_3389_fphys_2017_00873 crossref_primary_10_1016_j_jchf_2023_06_009 crossref_primary_10_1136_heartjnl_2019_315942 crossref_primary_10_1002_ejhf_1080 crossref_primary_10_1007_s11739_020_02468_z crossref_primary_10_1007_s10741_020_09933_z crossref_primary_10_1016_j_ijcard_2020_03_064 crossref_primary_10_1002_ejhf_3021 crossref_primary_10_3389_fcvm_2023_1142429 crossref_primary_10_1007_s12410_024_09597_5 crossref_primary_10_4103_apc_apc_235_20 crossref_primary_10_1007_s11897_023_00608_y crossref_primary_10_1016_j_hrthm_2024_05_051 crossref_primary_10_1016_j_jacc_2024_07_038 crossref_primary_10_1016_j_jacc_2025_05_061 crossref_primary_10_1007_s12471_024_01859_7 crossref_primary_10_1161_CIRCULATIONAHA_117_029932 crossref_primary_10_1038_s41467_019_10591_5 crossref_primary_10_1007_s00108_017_0341_x crossref_primary_10_1007_s00395_021_00897_1 crossref_primary_10_3390_diagnostics11101781 crossref_primary_10_1016_j_cardfail_2024_12_001 crossref_primary_10_1093_eurheartj_ehae326 crossref_primary_10_1161_CIRCULATIONAHA_123_065560 crossref_primary_10_3389_fcvm_2021_754499 crossref_primary_10_1007_s11886_020_01343_9 crossref_primary_10_1093_cvr_cvac013 crossref_primary_10_1093_eurheartj_ehac262 crossref_primary_10_1002_ejhf_1192 crossref_primary_10_1007_s11936_020_00828_8 crossref_primary_10_1016_j_repc_2019_03_006 crossref_primary_10_1093_ejcts_ezz107 crossref_primary_10_1097_MD_0000000000040083 crossref_primary_10_1093_eurheartj_ehz409 crossref_primary_10_1002_ejhf_1078 crossref_primary_10_1002_ejhf_2046 crossref_primary_10_1002_ejhf_2167 crossref_primary_10_1111_imj_14781 crossref_primary_10_1002_ejhf_2965 crossref_primary_10_1002_ejhf_1755 crossref_primary_10_1016_j_jchf_2020_06_015 crossref_primary_10_1002_ejhf_1994 crossref_primary_10_1007_s00392_018_1396_y crossref_primary_10_1002_ejhf_2845 crossref_primary_10_1161_CIRCHEARTFAILURE_122_009634 crossref_primary_10_1016_j_ahj_2018_11_009 crossref_primary_10_1038_s43856_024_00451_9 crossref_primary_10_1111_pace_13448 crossref_primary_10_1093_eurheartj_ehad347 crossref_primary_10_1093_eurheartj_ehz773 crossref_primary_10_1161_CIR_0000000000000757 crossref_primary_10_1016_j_cca_2018_12_022 crossref_primary_10_1038_s41569_025_01190_7 crossref_primary_10_1016_j_amjcard_2023_12_012 crossref_primary_10_1093_eurheartj_ehac136 crossref_primary_10_1007_s11897_023_00641_x crossref_primary_10_1016_j_ijcard_2019_05_046 crossref_primary_10_1161_CIR_0000000000001052 crossref_primary_10_15829_1560_4071_2024_6162 crossref_primary_10_1136_heartjnl_2019_316105 crossref_primary_10_3390_antiox9070641 crossref_primary_10_1016_j_jacep_2018_06_003 crossref_primary_10_1016_j_medcle_2020_10_022 crossref_primary_10_3390_jpm11121358 crossref_primary_10_1002_ehf2_12367 crossref_primary_10_1002_ejhf_1501 crossref_primary_10_1016_j_ahj_2020_11_012 crossref_primary_10_1016_j_cardfail_2025_02_014 crossref_primary_10_18087_cardio_2021_8_n1651 crossref_primary_10_1080_1354750X_2025_2553630 crossref_primary_10_1002_joa3_12651 crossref_primary_10_20538_1682_0363_2022_1_183_196 crossref_primary_10_1016_j_amjcard_2018_03_362 crossref_primary_10_1016_j_hrthm_2025_05_013 crossref_primary_10_1016_j_mpdhp_2017_09_003 crossref_primary_10_1002_ejhf_2818 crossref_primary_10_1016_j_jacadv_2025_102063 crossref_primary_10_1093_eurheartj_ehz860 crossref_primary_10_1161_JAHA_119_015563 crossref_primary_10_1016_j_hlc_2018_09_010 crossref_primary_10_1002_bmc_5012 crossref_primary_10_1016_j_ccl_2023_06_005 crossref_primary_10_1016_j_tcm_2018_05_001 crossref_primary_10_1161_CIRCULATIONAHA_119_043012 crossref_primary_10_1016_j_cpcardiol_2024_102747 crossref_primary_10_1002_joa3_70084 crossref_primary_10_3389_fcvm_2023_1211560 crossref_primary_10_1016_j_ijcchd_2020_100003 crossref_primary_10_1186_s40001_020_0401_x crossref_primary_10_1016_j_hlc_2025_03_015 crossref_primary_10_1016_j_medcli_2020_10_022 crossref_primary_10_1186_s12872_022_02811_6 crossref_primary_10_1016_j_rec_2019_09_030 crossref_primary_10_1002_ejhf_2029 crossref_primary_10_1016_j_jchf_2018_04_007 crossref_primary_10_1002_ejhf_2149 crossref_primary_10_1016_j_ahj_2022_07_003 crossref_primary_10_1016_j_jacc_2017_07_748 crossref_primary_10_1002_ejhf_1858 crossref_primary_10_1016_j_hrthm_2025_01_042 crossref_primary_10_1080_14656566_2021_2003329 crossref_primary_10_1007_s10741_020_09991_3 crossref_primary_10_1007_s15006_017_0172_7 crossref_primary_10_1093_eurheartj_ehaf668 crossref_primary_10_1016_j_ijbiomac_2025_143171 crossref_primary_10_1093_eurheartj_ehae334 crossref_primary_10_1089_jpm_2019_0044 crossref_primary_10_1161_JAHA_119_016309 crossref_primary_10_1016_j_acvd_2024_10_005 crossref_primary_10_1007_s11897_018_0416_6 crossref_primary_10_1016_j_amjcard_2020_01_019 crossref_primary_10_3390_jcdd9040120 crossref_primary_10_1016_j_jacc_2018_09_083 crossref_primary_10_1002_ejhf_1043 crossref_primary_10_1253_circj_CJ_25_0002 crossref_primary_10_1016_j_jjcc_2021_11_018 crossref_primary_10_1093_ehjqcco_qcaf018 crossref_primary_10_1016_j_jjcc_2019_06_001 crossref_primary_10_1177_03000605211053550 crossref_primary_10_1016_j_ijcard_2023_131595 crossref_primary_10_1016_j_jchf_2022_01_007 crossref_primary_10_3390_life13091940 crossref_primary_10_1002_joa3_12795 crossref_primary_10_1161_CIRCIMAGING_124_017246 crossref_primary_10_1002_ehf2_14086 crossref_primary_10_1148_radiol_252576 crossref_primary_10_1016_j_amjcard_2021_02_035 crossref_primary_10_1093_ehjqcco_qcae071 crossref_primary_10_3390_jcm11010121 crossref_primary_10_1056_NEJMoa2509542 crossref_primary_10_1016_j_ijcard_2018_03_089 crossref_primary_10_1016_j_rec_2021_07_022 crossref_primary_10_1186_s12933_024_02312_0 crossref_primary_10_1093_eurheartj_ehab253 crossref_primary_10_1002_ejhf_2120 crossref_primary_10_1016_j_pcad_2025_04_001 crossref_primary_10_3389_fphys_2021_650124 crossref_primary_10_1016_j_mayocp_2023_01_012 crossref_primary_10_1002_ejhf_2124 crossref_primary_10_1016_j_hrcr_2021_02_009 crossref_primary_10_36660_abc_20240348i crossref_primary_10_4070_kcj_2025_0052 crossref_primary_10_1016_j_jacep_2024_02_034 crossref_primary_10_1007_s00392_018_1378_0 crossref_primary_10_1093_eurheartj_ehab368 crossref_primary_10_1016_j_hrthm_2018_09_031 crossref_primary_10_1007_s15027_017_1187_9 crossref_primary_10_1111_jce_16473 crossref_primary_10_1161_CIR_0000000000000950 crossref_primary_10_1007_s00399_024_01041_x crossref_primary_10_1161_CIR_0000000000001123 crossref_primary_10_36660_abc_20240348 crossref_primary_10_1161_JAHA_123_032465 crossref_primary_10_1056_NEJMc1711901 crossref_primary_10_1002_ehf2_13810 crossref_primary_10_1002_ejhf_2594 crossref_primary_10_1016_j_jelectrocard_2019_09_001 crossref_primary_10_1002_ejhf_1382 crossref_primary_10_1016_j_cardfail_2022_11_016 crossref_primary_10_1016_j_jacep_2018_04_015 crossref_primary_10_1111_anec_12985 crossref_primary_10_1161_CIRCHEARTFAILURE_123_010606 crossref_primary_10_1161_CIRCEP_119_007430 crossref_primary_10_1016_j_amjcard_2019_05_055 crossref_primary_10_1002_ejhf_2911 crossref_primary_10_3390_jcm13051316 crossref_primary_10_1016_j_jcmg_2019_10_021 crossref_primary_10_1007_s00392_023_02281_6 crossref_primary_10_1016_j_jacc_2024_08_052 crossref_primary_10_1016_j_lpm_2023_104192 crossref_primary_10_1093_eurheartj_ehz788 crossref_primary_10_1093_eurheartj_ehz427 crossref_primary_10_1186_s12933_020_01024_5 crossref_primary_10_1002_ehf2_13586 crossref_primary_10_1002_ejhf_1135 crossref_primary_10_1038_s41591_023_02567_2 crossref_primary_10_36290_kar_2022_019 crossref_primary_10_1007_s11897_020_00494_8 crossref_primary_10_1161_CIRCRESAHA_118_312708 crossref_primary_10_3389_fcvm_2024_1340708 crossref_primary_10_1016_j_cjca_2021_01_024 crossref_primary_10_1161_JAHA_124_040340 crossref_primary_10_1016_j_amjcard_2023_10_044 crossref_primary_10_3390_jcm14093257 crossref_primary_10_1002_ejhf_1914 crossref_primary_10_1016_j_jacep_2022_06_016 crossref_primary_10_1093_eurheartj_ehy344 crossref_primary_10_1007_s40258_020_00571_y crossref_primary_10_1093_eurheartj_ehz553 crossref_primary_10_1016_j_jjcc_2025_01_006 crossref_primary_10_1186_s12962_022_00384_x crossref_primary_10_1016_j_jamda_2018_10_031 crossref_primary_10_1093_eurheartj_ehaa970 crossref_primary_10_1016_j_clinme_2025_100497 crossref_primary_10_1161_JAHA_119_015139 crossref_primary_10_1007_s11897_023_00642_w crossref_primary_10_1161_CIRCULATIONAHA_121_056072 crossref_primary_10_1002_ehf2_12701 crossref_primary_10_1002_ejhf_2333 crossref_primary_10_1007_s12350_017_1046_1 crossref_primary_10_1186_s13014_022_02000_x crossref_primary_10_36660_abc_20201086 crossref_primary_10_1007_s00392_024_02441_2 crossref_primary_10_1161_CIRCHEARTFAILURE_122_009669 crossref_primary_10_1002_ehf2_12385 crossref_primary_10_1002_ejhf_1803 crossref_primary_10_1007_s12181_020_00385_1 crossref_primary_10_1093_eurheartj_suz212 crossref_primary_10_1186_s11658_019_0165_x crossref_primary_10_1093_eurheartj_ehz364 crossref_primary_10_1007_s00392_019_01415_z crossref_primary_10_1093_ehjcr_ytac074 crossref_primary_10_1007_s00059_019_04877_z crossref_primary_10_1097_HCO_0000000000000710 crossref_primary_10_1016_S0140_6736_19_31996_8 crossref_primary_10_1016_j_carpath_2018_10_009 crossref_primary_10_1161_JAHA_121_022733 crossref_primary_10_1016_j_jcmg_2019_01_043 crossref_primary_10_1002_ehf2_15100 crossref_primary_10_1016_j_jchf_2019_08_001 crossref_primary_10_1016_S0140_6736_18_31808_7 crossref_primary_10_1097_MJT_0000000000000836 crossref_primary_10_2459_JCM_0000000000000584 crossref_primary_10_1002_ejhf_3417 crossref_primary_10_1161_CIRCHEARTFAILURE_119_006746 crossref_primary_10_1093_eurheartj_ehz010 crossref_primary_10_1136_heartjnl_2022_321728 crossref_primary_10_3390_diagnostics14111173 crossref_primary_10_1161_JAHA_123_031977 crossref_primary_10_1093_eurheartj_ehab560 crossref_primary_10_1136_heartjnl_2021_319344 crossref_primary_10_1002_ehf2_12407 crossref_primary_10_1097_01_JAA_0000550282_19722_93 crossref_primary_10_1016_j_phymed_2024_156252 crossref_primary_10_1007_s12012_021_09678_7 crossref_primary_10_1053_j_jvca_2022_03_012 crossref_primary_10_1080_14656566_2023_2223964 crossref_primary_10_1016_j_jchf_2019_03_019 crossref_primary_10_1111_imj_15103 crossref_primary_10_1002_ejhf_3641 crossref_primary_10_1007_s10741_018_9713_0 crossref_primary_10_1016_j_cardfail_2019_07_455 crossref_primary_10_1007_s00399_018_0600_0 crossref_primary_10_1002_ejhf_3647 crossref_primary_10_1111_ctr_13490 crossref_primary_10_1161_CIRCHEARTFAILURE_122_009922 crossref_primary_10_1002_ejhf_1587 crossref_primary_10_1007_s10840_024_01873_0 crossref_primary_10_1136_bmjopen_2024_094764 crossref_primary_10_1002_ejhf_1109 crossref_primary_10_1016_j_jchf_2018_02_001 crossref_primary_10_1016_j_ccep_2018_11_001 crossref_primary_10_1016_j_jcmg_2018_07_002 crossref_primary_10_1161_JAHA_120_018090 crossref_primary_10_15420_aer_2019_13_2 crossref_primary_10_3390_jcm13133858 crossref_primary_10_1093_europace_euac061 crossref_primary_10_1186_s13019_024_03221_9 crossref_primary_10_1093_cvr_cvae054 crossref_primary_10_1002_ehf2_12978 crossref_primary_10_1161_CIRCULATIONAHA_122_062159 crossref_primary_10_1002_ejhf_3076 crossref_primary_10_1089_jwh_2020_8475 crossref_primary_10_1016_j_pcad_2019_04_004 crossref_primary_10_1002_ehf2_14113 crossref_primary_10_1002_ejhf_1216 crossref_primary_10_1016_j_hrthm_2024_09_003 crossref_primary_10_3390_s22052037 crossref_primary_10_1016_j_cdtm_2018_08_005 crossref_primary_10_3390_ijms21176320 crossref_primary_10_1038_s44172_024_00307_z crossref_primary_10_1161_JAHA_119_015177 crossref_primary_10_15829_29_1560_4071_2020_4083 crossref_primary_10_3390_jcm9030893 crossref_primary_10_1093_eurheartj_ehz238 crossref_primary_10_2478_jtim_2023_0088 crossref_primary_10_1161_CIRCULATIONAHA_118_035627 crossref_primary_10_1016_j_rec_2020_03_027 crossref_primary_10_1016_j_amjcard_2020_04_038 crossref_primary_10_1016_j_eclinm_2025_103337 crossref_primary_10_1111_pace_14150 crossref_primary_10_1161_JAHA_118_009684 crossref_primary_10_1093_bmb_ldx051 crossref_primary_10_1002_ejhf_2530 crossref_primary_10_3390_life13010250 crossref_primary_10_1136_bmjopen_2017_021108 crossref_primary_10_1093_eurheartj_ehab903 crossref_primary_10_1002_ejhf_2419 crossref_primary_10_1002_ejhf_1569 |
| Cites_doi | 10.1016/S0735-1097(98)00609-3 10.1161/CIRCHEARTFAILURE.110.959882 10.1016/j.amjcard.2008.07.045 10.1161/01.CIR.0000144474.65922.AA 10.1016/S0140-6736(98)11181-9 10.1016/j.hrthm.2013.01.008 10.1016/j.amjcard.2011.10.033 10.1056/NEJMoa0706201 10.1161/01.CIR.94.11.2807 10.1016/j.amjmed.2010.08.017 10.1186/1471-2261-13-52 10.1016/j.jacc.2008.05.058 10.1007/s10557-015-6572-y 10.1056/NEJMoa013474 10.1161/CIR.0b013e31829e8807 10.1056/NEJMoa043399 10.1016/S0140-6736(03)14283-3 10.1056/NEJMoa1409077 10.1056/NEJM199909023411001 10.1056/NEJM200105313442202 10.1056/NEJMoa010713 10.1093/eurheartj/ehv186 10.1016/S0140-6736(99)04440-2 10.1016/S0735-1097(02)02063-6 10.1161/CIRCHEARTFAILURE.112.000003 10.1056/NEJMoa1009492 10.1056/NEJMoa1608029 10.1056/NEJMcp0909392 10.1161/CIRCULATIONAHA.106.666016 10.1016/j.jacc.2010.04.016 10.1016/S0140-6736(03)14284-5 10.1016/S0140-6736(08)61240-4 10.1093/europace/eus427 10.2307/2670170 10.1093/eurjhf/hfs105 10.1161/01.CIR.88.5.2277 10.1023/B:CARD.0000025756.32499.6f |
| ContentType | Journal Article |
| Copyright | Copyright © 2017 Massachusetts Medical Society. All rights reserved. |
| Copyright_xml | – notice: Copyright © 2017 Massachusetts Medical Society. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7RV 7X7 7XB 8AO 8C1 8FE 8FH 8FI ABUWG AFKRA AN0 AZQEC BBNVY BEC BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH HCIFZ K0Y LK8 M0R M0T M1P M2M M2O M2P M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 ADTPV AOWAS F1U |
| DOI | 10.1056/NEJMoa1609758 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database ProQuest Central Essentials Biological Science Collection eLibrary ProQuest Central Natural Science Collection ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep SciTech Premium Collection New England Journal of Medicine ProQuest Biological Science Collection Consumer Health Database Healthcare Administration Database PML(ProQuest Medical Library) Psychology Database ProQuest Research Library Science Database (ProQuest) Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic SwePub SwePub Articles SWEPUB Göteborgs universitet |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials elibrary ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing New England Journal of Medicine ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Research Library ProQuest Central (New) ProQuest Public Health ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest Family Health ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest One Psychology |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7RV name: Nursing & Allied Health Database url: https://search.proquest.com/nahs sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1533-4406 |
| EndPage | 51 |
| ExternalDocumentID | oai_gup_ub_gu_se_255565 28679089 10_1056_NEJMoa1609758 NJ201707063770108 |
| Genre | Original Article Journal Article |
| GroupedDBID | - 0R 0WA 123 186 1VV 29N 2KS 2WC 34G 39C 3V. 4 4.4 53G 55 5RE 7FN 7RV 7X7 85S 8AO 8C1 8FE 8FH 8FI AACLI AAEJM AAIKC AALRV AAPBV AAQQT AARDX AAWTL ABACO ABEHJ ABFLS ABIVO ABOCM ABPPZ ABPTK ABQIJ ABUWG ABWJO ACGFS ACGOD ACJLH ACNCT ACPRK ACRZS ADBBV ADBIT ADCBC ADRHT AENEX AETEA AFFNX AFHKK AFKRA AGFXO AGNAY AHMBA AJJEV AJVPN ALMA_UNASSIGNED_HOLDINGS AN0 AQUVI AZQEC BBAFP BBNVY BCU BENPR BES BHPHI BKEYQ BKNYI BLC BNQBC BPHCQ BVXVI C45 CJ0 CO CS3 DCD DU5 DWQXO DZ EBS EJD ET EX3 F5P FD8 FM. FYUFA GJ GNUQQ GUQSH H13 HCIFZ HZ I4R IH2 K-O KM KOO L7B LK8 M0R M0T M1P M2M M2O M2P M7P MVM N9A NAPCQ NEJ O9- OK1 OMK OVD P-O P-S P2P PADUT PCD PQEST PQQKQ PQUKI PRINS PROAC PSQYO QJJ RHI RWL RXW S10 S6N SJFOW SJN TAE TAF TEORI TN5 TUQ TWZ UCV UKR UMD VQA W2G WH7 WOQ WOW X X7M XJT XYN XZL YCJ YNT YRY YZZ ZA5 ZHY ZR0 --- -DZ -ET -~X .-4 .55 .CO .GJ 0R~ 36B AAMNW AAQOH AAYXX ABBLC ABCQX ABDQB ABJNI ABUFD ACKOT ACPFK ADUKH AERZD AFFHD AGHSJ BYPQX CCPQU CITATION HF~ HMCUK HZ~ N4W PHGZM PHGZT PJZUB PPXIY PQGLB PSYQQ UKHRP YFH YR2 YR5 YYP ZCA ZVN ~KM AFOSN ALIPV CGR CUY CVF ECM EIF NPM UIG 7XB BEC K0Y MBDVC PKEHL Q9U 7X8 PUEGO 1CY 1KJ 3O- 41~ 6TJ 8WZ 9M8 A6W AAUTI ABDPE ABEFU ACPVT ACTDY ADTPV ADXHL AFFDN AJUXI AOWAS D0S F1U FA8 J5H LPU MQT NHB OHT QZG SKT UBX UQL WHG YHZ YQI YQJ YYQ ZGI ZKB ZXP |
| ID | FETCH-LOGICAL-c428t-186676f8456f83d18ebb3d5e0b8e46d649fbf9b97aa5081a1d14d44db3dfa2bb3 |
| IEDL.DBID | M2P |
| ISICitedReferencesCount | 390 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000404730000007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0028-4793 1533-4406 |
| IngestDate | Tue Nov 04 16:24:10 EST 2025 Thu Oct 02 05:32:15 EDT 2025 Sat Nov 29 14:33:02 EST 2025 Thu Apr 03 07:03:07 EDT 2025 Tue Nov 18 22:20:18 EST 2025 Sat Nov 29 03:01:55 EST 2025 Tue Dec 21 14:38:52 EST 2021 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c428t-186676f8456f83d18ebb3d5e0b8e46d649fbf9b97aa5081a1d14d44db3dfa2bb3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1609758?articleTools=true |
| PMID | 28679089 |
| PQID | 1916467086 |
| PQPubID | 40644 |
| PageCount | 11 |
| ParticipantIDs | swepub_primary_oai_gup_ub_gu_se_255565 proquest_miscellaneous_1916709829 proquest_journals_1916467086 pubmed_primary_28679089 crossref_citationtrail_10_1056_NEJMoa1609758 crossref_primary_10_1056_NEJMoa1609758 mms_nejm_10_1056_NEJMoa1609758 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-07-06 |
| PublicationDateYYYYMMDD | 2017-07-06 |
| PublicationDate_xml | – month: 07 year: 2017 text: 2017-07-06 day: 06 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Boston |
| PublicationTitle | The New England journal of medicine |
| PublicationTitleAlternate | N Engl J Med |
| PublicationYear | 2017 |
| Publisher | Massachusetts Medical Society |
| Publisher_xml | – name: Massachusetts Medical Society |
| References | Wong, M, Staszewsky, L, Latini, R (r030) 2002; 40 Al-Gobari, M, El Khatib, C, Pillon, F, Gueyffier, F (r009) 2013; 13 (r016) 1999; 353 Tung, R, Zimetbaum, P, Josephson, ME (r006) 2008; 52 Kjekshus, J, Apetrei, E, Barrios, V (r020) 2007; 357 Desai, AS, McMurray, JJ, Packer, M (r011) 2015; 36 McMurray, JJV (r001) 2010; 362 McMurray, JJV, Östergren, J, Swedberg, K (r019) 2003; 362 Zecchin, M, Merlo, M, Pivetta, A (r032) 2012; 109 Køber, L, Thune, JJ, Nielsen, JC (r012) 2016; 375 Solomon, SD, Wang, D, Finn, P (r008) 2004; 110 Bapoje, SR, Bahia, A, Hokanson, JE (r010) 2013; 6 Fine, JP, Gray, RJ (r024) 1999; 94 Bristow, MR, Gilbert, EM, Abraham, WT (r031) 1996; 94 Remme, WJ, Riegger, G, Hildebrandt, P (r028) 2004; 18 Colucci, WS, Kolias, TJ, Adams, KF (r027) 2007; 116 Bardy, GH, Lee, KL, Mark, DB (r002) 2005; 352 Russo, AM, Stainback, RF, Bailey, SR (r026) 2013; 10 Konstam, MA, Kronenberg, MW, Rousseau, MF (r029) 1993; 88 Moss, AJ, Zareba, W, Hall, WJ (r003) 2002; 346 Pitt, B, Zannad, F, Remme, WJ (r013) 1999; 341 Domanski, MJ, Exner, DV, Borkowf, CB, Geller, NL, Rosenberg, Y, Pfeffer, MA (r007) 1999; 33 Fonarow, GC, Abraham, WT, Albert, NM (r035) 2008; 102 Granger, CB, McMurray, JJV, Yusuf, S (r018) 2003; 362 Yancy, CW, Jessup, M, Bozkurt, B (r004) 2013; 128 Zannad, F, McMurray, JJV, Krum, H (r022) 2011; 364 McMurray, JJV, Packer, M, Desai, AS (r023) 2014; 371 Betts, TR, Sadarmin, PP, Tomlinson, DR (r025) 2013; 15 Chung, MK, Szymkiewicz, SJ, Shao, M (r037) 2010; 56 Cohn, JN, Tognoni, G (r017) 2001; 345 (r015) 1999; 353 (r014) 2001; 344 McMurray, JJ, Adamopoulos, S, Anker, SD (r005) 2012; 14 Tavazzi, L, Maggioni, AP, Marchioli, R (r021) 2008; 372 Cubbon, RM, Gale, CP, Kearney, LC (r036) 2011; 4 Eschalier, R, Chenaf, C, Mulliez, A (r034) 2015; 29 Wong, CY, Chaudhry, SI, Desai, MM, Krumholz, HM (r033) 2011; 124 r020 r021 r022 r001 r023 r017 r018 r019 r013 r035 r014 r036 r015 r037 r016 r031 r010 r032 r011 r033 r012 r034 r030 r006 r028 r007 r029 r008 r009 r002 r024 r003 r025 r004 r026 r005 r027 29094860 - N Engl J Med. ;377(18):1793-4 29094861 - N Engl J Med. ;377(18):1794 29071618 - MMW Fortschr Med. 2017 Oct;159(18):37 29094859 - N Engl J Med. ;377(18):1793 |
| References_xml | – volume: 353 start-page: 9 year: 1999 end-page: 13 ident: r015 article-title: The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. publication-title: Lancet ;CIBIS-II Investigators and Committees – volume: 13 start-page: 52 year: 2013 end-page: 52 ident: r009 article-title: β-Blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials. publication-title: BMC Cardiovasc Disord – volume: 352 start-page: 225 year: 2005 end-page: 237 ident: r002 article-title: Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure. publication-title: N Engl J Med – volume: 128 start-page: e240 year: 2013 end-page: e327 ident: r004 article-title: 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. publication-title: Circulation – volume: 56 start-page: 194 year: 2010 end-page: 203 ident: r037 article-title: Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. publication-title: J Am Coll Cardiol – volume: 94 start-page: 496 year: 1999 end-page: 509 ident: r024 article-title: A proportional hazards model for the subdistribution of a competing risk. publication-title: J Am Stat Assoc – volume: 353 start-page: 2001 year: 1999 end-page: 2007 ident: r016 article-title: Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) publication-title: Lancet ;MERIT-HF Study Group – volume: 18 start-page: 57 year: 2004 end-page: 66 ident: r028 article-title: The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction: the Carvedilol and ACE-inhibitor Remodelling Mild Heart Failure Evaluation trial (CARMEN). publication-title: Cardiovasc Drugs Ther – volume: 52 start-page: 1111 year: 2008 end-page: 1121 ident: r006 article-title: A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. publication-title: J Am Coll Cardiol – volume: 110 start-page: 2180 year: 2004 end-page: 2183 ident: r008 article-title: Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. publication-title: Circulation – volume: 371 start-page: 993 year: 2014 end-page: 1004 ident: r023 article-title: Angiotensin–neprilysin inhibition versus enalapril in heart failure. publication-title: N Engl J Med – volume: 346 start-page: 877 year: 2002 end-page: 883 ident: r003 article-title: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. publication-title: N Engl J Med – volume: 116 start-page: 49 year: 2007 end-page: 56 ident: r027 article-title: Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial. publication-title: Circulation – volume: 357 start-page: 2248 year: 2007 end-page: 2261 ident: r020 article-title: Rosuvastatin in older patients with systolic heart failure. publication-title: N Engl J Med – volume: 375 start-page: 1221 year: 2016 end-page: 1230 ident: r012 article-title: Defibrillator implantation in patients with nonischemic systolic heart failure. publication-title: N Engl J Med – volume: 14 start-page: 803 year: 2012 end-page: 869 ident: r005 article-title: ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology: developed in collaboration with the Heart Failure Association (HFA) of the ESC. publication-title: Eur J Heart Fail – volume: 6 start-page: 166 year: 2013 end-page: 173 ident: r010 article-title: Effects of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with left ventricular systolic dysfunction: a meta-analysis of randomized controlled trials. publication-title: Circ Heart Fail – volume: 372 start-page: 1231 year: 2008 end-page: 1239 ident: r021 article-title: Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. publication-title: Lancet – volume: 362 start-page: 772 year: 2003 end-page: 776 ident: r018 article-title: Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. publication-title: Lancet – volume: 15 start-page: 813 year: 2013 end-page: 819 ident: r025 article-title: Absolute risk reduction in total mortality with implantable cardioverter defibrillators: analysis of primary and secondary prevention trial data to aid risk/benefit analysis. publication-title: Europace – volume: 33 start-page: 598 year: 1999 end-page: 604 ident: r007 article-title: Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction: a meta-analysis of randomized clinical trials. publication-title: J Am Coll Cardiol – volume: 40 start-page: 970 year: 2002 end-page: 975 ident: r030 article-title: Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study. publication-title: J Am Coll Cardiol – volume: 362 start-page: 767 year: 2003 end-page: 771 ident: r019 article-title: Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. publication-title: Lancet – volume: 94 start-page: 2807 year: 1996 end-page: 2816 ident: r031 article-title: Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. publication-title: Circulation – volume: 344 start-page: 1659 year: 2001 end-page: 1667 ident: r014 article-title: A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. publication-title: N Engl J Med ;The Beta-Blocker Evaluation of Survival Trial Investigators – volume: 362 start-page: 228 year: 2010 end-page: 238 ident: r001 article-title: Systolic heart failure. publication-title: N Engl J Med – volume: 102 start-page: 1524 year: 2008 end-page: 1529 ident: r035 article-title: Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure). publication-title: Am J Cardiol – volume: 124 start-page: 136 year: 2011 end-page: 143 ident: r033 article-title: Trends in comorbidity, disability, and polypharmacy in heart failure. publication-title: Am J Med – volume: 4 start-page: 396 year: 2011 end-page: 403 ident: r036 article-title: Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic eras. publication-title: Circ Heart Fail – volume: 88 start-page: 2277 year: 1993 end-page: 2283 ident: r029 article-title: Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. publication-title: Circulation – volume: 29 start-page: 89 year: 2015 end-page: 98 ident: r034 article-title: Impact of clinical characteristics and management on the prognosis of unselected heart failure patients. publication-title: Cardiovasc Drugs Ther – volume: 36 start-page: 1990 year: 2015 end-page: 1997 ident: r011 article-title: Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients. publication-title: Eur Heart J – volume: 109 start-page: 729 year: 2012 end-page: 735 ident: r032 article-title: How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with “SCD-HeFT criteria?” publication-title: Am J Cardiol – volume: 345 start-page: 1667 year: 2001 end-page: 1675 ident: r017 article-title: A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. publication-title: N Engl J Med – volume: 10 start-page: e11 year: 2013 end-page: e58 ident: r026 article-title: ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. publication-title: Heart Rhythm – volume: 364 start-page: 11 year: 2011 end-page: 21 ident: r022 article-title: Eplerenone in patients with systolic heart failure and mild symptoms. publication-title: N Engl J Med – volume: 341 start-page: 709 year: 1999 end-page: 717 ident: r013 article-title: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. publication-title: N Engl J Med – ident: r007 doi: 10.1016/S0735-1097(98)00609-3 – ident: r036 doi: 10.1161/CIRCHEARTFAILURE.110.959882 – ident: r035 doi: 10.1016/j.amjcard.2008.07.045 – ident: r008 doi: 10.1161/01.CIR.0000144474.65922.AA – ident: r015 doi: 10.1016/S0140-6736(98)11181-9 – ident: r026 doi: 10.1016/j.hrthm.2013.01.008 – ident: r032 doi: 10.1016/j.amjcard.2011.10.033 – ident: r020 doi: 10.1056/NEJMoa0706201 – ident: r031 doi: 10.1161/01.CIR.94.11.2807 – ident: r033 doi: 10.1016/j.amjmed.2010.08.017 – ident: r009 doi: 10.1186/1471-2261-13-52 – ident: r006 doi: 10.1016/j.jacc.2008.05.058 – ident: r034 doi: 10.1007/s10557-015-6572-y – ident: r003 doi: 10.1056/NEJMoa013474 – ident: r004 doi: 10.1161/CIR.0b013e31829e8807 – ident: r002 doi: 10.1056/NEJMoa043399 – ident: r019 doi: 10.1016/S0140-6736(03)14283-3 – ident: r023 doi: 10.1056/NEJMoa1409077 – ident: r013 doi: 10.1056/NEJM199909023411001 – ident: r014 doi: 10.1056/NEJM200105313442202 – ident: r017 doi: 10.1056/NEJMoa010713 – ident: r011 doi: 10.1093/eurheartj/ehv186 – ident: r016 doi: 10.1016/S0140-6736(99)04440-2 – ident: r030 doi: 10.1016/S0735-1097(02)02063-6 – ident: r010 doi: 10.1161/CIRCHEARTFAILURE.112.000003 – ident: r022 doi: 10.1056/NEJMoa1009492 – ident: r012 doi: 10.1056/NEJMoa1608029 – ident: r001 doi: 10.1056/NEJMcp0909392 – ident: r027 doi: 10.1161/CIRCULATIONAHA.106.666016 – ident: r037 doi: 10.1016/j.jacc.2010.04.016 – ident: r018 doi: 10.1016/S0140-6736(03)14284-5 – ident: r021 doi: 10.1016/S0140-6736(08)61240-4 – ident: r025 doi: 10.1093/europace/eus427 – ident: r024 doi: 10.2307/2670170 – ident: r005 doi: 10.1093/eurjhf/hfs105 – ident: r029 doi: 10.1161/01.CIR.88.5.2277 – ident: r028 doi: 10.1023/B:CARD.0000025756.32499.6f – reference: 29071618 - MMW Fortschr Med. 2017 Oct;159(18):37 – reference: 29094860 - N Engl J Med. ;377(18):1793-4 – reference: 29094861 - N Engl J Med. ;377(18):1794 – reference: 29094859 - N Engl J Med. ;377(18):1793 |
| SSID | ssj0000149 |
| Score | 2.660245 |
| Snippet | Data were analyzed from 40,195 patients with heart failure with reduced ejection fraction enrolled in 12 clinical trials in the 1995–2014 period. Sudden-death... The risk of sudden death has changed over time among patients with symptomatic heart failure and reduced ejection fraction with the sequential introduction of... BackgroundThe risk of sudden death has changed over time among patients with symptomatic heart failure and reduced ejection fraction with the sequential... BACKGROUND The risk of sudden death has changed over time among patients with symptomatic heart failure and reduced ejection fraction with the sequential... |
| SourceID | swepub proquest pubmed crossref mms |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 41 |
| SubjectTerms | Adult Age Factors Aged Angiotensin candesartan Cardiac arrhythmia cardiac death Cardiology Cardiovascular diseases Cause of Death Clinical Medicine Clinical trials Confounding Factors, Epidemiologic converting-enzyme inhibitors Death Death, Sudden - epidemiology Defibrillators dysfunction Female Follow-Up Studies General & Internal Medicine Health risk assessment Heart diseases Heart failure Heart Failure - mortality Heart Failure - physiopathology Humans implantable cardioverter-defibrillator Incidence Ischemia Klinisk medicin Male metaanalysis Middle Aged Mortality myocardial-infarction Patients Peptidyl-dipeptidase A prevention Randomized Controlled Trials as Topic randomized controlled-trials Regression Analysis Risk Sex Factors Stroke Volume ventricular systolic |
| SummonAdditionalLinks | – databaseName: New England Journal of Medicine dbid: DCD link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZT8MwDLa4hHjhPsalICGeqNYj65JHxJh4ASEOibcoaZNpwLqJrvx-7LabOIV4bVzJih3nc5x8BjjmwjlNBXeT-sbjtqXpEoDzfEcuLVIT6arZRPv6Wjw-ypsZaE7ewmT2aVAW8GlF0wn0pDt8k3rDD3UQ-xIh7izMk6-RG3fOOx_4omq8Wx8Z1aSa337_tAnNDgb5T_jyC3loueF0V_6t6ios19iSnVXOsAYzNluHxau6er4BzY4tH0JmPXbbz5_Z0LG7ggIP6xAQZP2MXaLjj1lX9-m2-iY8dC_uzy-9umGCl2AWMfaIvK4dO4GgyIkoDYQ1Jkpb1jfC8jiNuXTGSSPbWiMuC3SQBjzlHA2SOh2i7BbMZcPM7gATTjrpJ3FkAsMxnpuAmygKLQoHiUlEA04nM6iSmk2cmlq8qLKq3YrVp0lowMlUfFTRaPwmeIjmUDS3vwnsTyyl6uWWK0w6Y4z4mJ414Gg6jAuFqh86s8Oikmn7UoSyAduVhaeqhEQ76AscOalMPh0h9u1eMVL4qVeo3CpMwRAD7_6l5h4shQQAysuF-zA3fi3sASwkb-N-_npYeu07jfPlRQ priority: 102 providerName: Massachusetts Medical Society |
| Title | Declining Risk of Sudden Death in Heart Failure |
| URI | https://nejm.org/doi/full/10.1056/NEJMoa1609758 https://www.ncbi.nlm.nih.gov/pubmed/28679089 https://www.proquest.com/docview/1916467086 https://www.proquest.com/docview/1916709829 https://gup.ub.gu.se/publication/255565 |
| Volume | 377 |
| WOSCitedRecordID | wos000404730000007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVBGY databaseName: New England Journal of Medicine customDbUrl: eissn: 1533-4406 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000149 issn: 0028-4793 databaseCode: DCD dateStart: 19900101 isFulltext: true titleUrlDefault: https://www.nejm.org/medical-index providerName: Massachusetts Medical Society – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1533-4406 dateEnd: 20250912 omitProxy: false ssIdentifier: ssj0000149 issn: 0028-4793 databaseCode: M7P dateStart: 19800103 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Consumer Health Database customDbUrl: eissn: 1533-4406 dateEnd: 20250912 omitProxy: false ssIdentifier: ssj0000149 issn: 0028-4793 databaseCode: M0R dateStart: 19800103 isFulltext: true titleUrlDefault: https://search.proquest.com/familyhealth providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1533-4406 dateEnd: 20250912 omitProxy: false ssIdentifier: ssj0000149 issn: 0028-4793 databaseCode: 7X7 dateStart: 19800103 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Healthcare Administration Database customDbUrl: eissn: 1533-4406 dateEnd: 20250912 omitProxy: false ssIdentifier: ssj0000149 issn: 0028-4793 databaseCode: M0T dateStart: 19800103 isFulltext: true titleUrlDefault: https://search.proquest.com/healthmanagement providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1533-4406 dateEnd: 20250912 omitProxy: false ssIdentifier: ssj0000149 issn: 0028-4793 databaseCode: 7RV dateStart: 19800103 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1533-4406 dateEnd: 20250912 omitProxy: false ssIdentifier: ssj0000149 issn: 0028-4793 databaseCode: BENPR dateStart: 19800103 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Research Library customDbUrl: eissn: 1533-4406 dateEnd: 20250912 omitProxy: false ssIdentifier: ssj0000149 issn: 0028-4793 databaseCode: M2O dateStart: 19800103 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVPQU databaseName: Psychology Database customDbUrl: eissn: 1533-4406 dateEnd: 20250912 omitProxy: false ssIdentifier: ssj0000149 issn: 0028-4793 databaseCode: M2M dateStart: 19800103 isFulltext: true titleUrlDefault: https://www.proquest.com/psychology providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1533-4406 dateEnd: 20250912 omitProxy: false ssIdentifier: ssj0000149 issn: 0028-4793 databaseCode: 8C1 dateStart: 19800103 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database (ProQuest) customDbUrl: eissn: 1533-4406 dateEnd: 20250912 omitProxy: false ssIdentifier: ssj0000149 issn: 0028-4793 databaseCode: M2P dateStart: 19800103 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nj9MwEB3RXYS48L1QWKogoT0RNU7SxD4haLfaS0tUFtRbZCd2VaBJ2TT8fmYctyyI5cLlSYnnYGU842fPZAbgdcyNkRRwV2Wg_FiPJCUBGD8wtKR5qSLZNZtI53O-XIrMXbg1Lq1y7xOtoy7rgu7Ih3iuSNCokYG_3X73qWsURVddC40eHCOzYZTSNQuza-WjHP11N0iuxibu-UPqNF9LlgQipW7v1_ak3mbT_I1u_lFL1O4_0_v_O_MHcM8xT-9dt1Qewi1dPYI7MxdbfwzDiba_SVYrb7Fuvnq18T625Ja8CdFEb115F2gWO28q15TL_gQ-Tc8vxxe-a6fgF3jG2PlU2i5NDEfKZHhUMq6VisqRDhTXcVImsTDKCCVSKZG1MclKFpdxjOoqjQxR9gSOqrrSz8DjRhgRFEmkmIrR2ysWqygKNQqzQhW8D2_2HzQvXK1xannxLbcx71GS__b9-3B2EN92RTZuEhygdvJKf9ncJHC610HujLHJfymgD68Ow2hGFBuRla7bTiYNBA9FH552Cj9MJaSihAHHkbNuBRxGqDb3qt3m-GrV5o3O8YCGDPn5v2fxAu6GRA5s4uEpHO2uWv0Sbhc_duvmagC9dPGZcJla5Ih8zAZw_P58ni3waTKeIM6ChcVLwnBm8YPFjDDNfgLzdgCp |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB61BQEX3o-FUowEPRFtHt7EOSCEWFZbtV1VUKTeXDu2V9uyydJsQPwpfiMzeSwFUW49cI1H0SgzHn-TGX8D8IIL5xQV3LXxtcftQFETgPN8Ry4tjI5UM2wimUzE0VF6sAY_ursw1FbZxcQ6UJsio3_kfcwrYtzUiMDfLL54NDWKqqvdCI3GLXbt92-YspWvd4Zo35dhOHp_-G7stVMFvAyh9tIjhrckdgKRgxORCYTVOjID62theWxinjrtUp0mSiF4CVRgAm44R62NUyHK4nvX4QonZjFqFQwPztFVtXC7_WPVcnoixujTZPtCBbGfJjRd_twZuD6fl3-Dt39wl9bn3ejW__albsPNFlmzt81WuANrNr8L1_bb3oF70B_a-hpoPmUfZuUpKxz7WFHYZUOCwWyWszFqvWQjNaNe_fvw6VLUfQAbeZHbR8CES13qZ3GkA83xNNMB11EUWhQOMp2JHrzqDCizlkudRnp8lnVNfxDL3-zdg-2V-KIhEblIcAu9Qeb2ZH6RwGZnc9kGm1L-MngPnq-WMUxQ7UfltqgamcRPRZj24GHjYCtVQiJd9AWubDcet1oh7vFptZD4aFrJ0kpMQDEDePxvLZ7B9fHh_p7c25nsPoEbIQGhuslyEzaWZ5V9Clezr8tZebZVbx8Gx5fthT8BdUFUSA |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB61BVW9lHdZKMVI0BPR5uFNnANCiGXVqnRVFZB6M3Zsr7Zlk22zAfHX-HXM5LEURLn1wDUeRZPMePzZM_4G4DkXzilKuGvja4_bgaIiAOf5jlxaGB2pptlEMh6Lk5P0aAV-dHdhqKyyi4l1oDZFRmfkfdxXxDipqS-Qa8sijoaj1_NzjzpIUaa1a6fRuMiB_f4Nt2_lq_0h2vpFGI7efXy757UdBrwMYffCI7a3JHYCUYQTkQmE1ToyA-trYXlsYp467VKdJkohkAlUYAJuOMcvME6FKIvvXYUbCR-ExNt_6B9foq5qoXd7etXyeyLe6FOX-0IFsZ8m1Gn-0nq4OpuVf4O6f_CY1mvf6Nb__Nduw2aLuNmbZorcgRWb34X1w7am4B70h7a-HppP2PG0PGOFYx8qCsdsSPCYTXO2h1ov2EhNqYb_Pny6FnUfwFpe5PYhMOFSl_pZHOlAc1zldMB1FIUWhYNMZ6IHLztjyqzlWKdWH19knesfxPI32_dgdyk-b8hFrhLcQc-QuT2dXSWw3dlftkGolL-M34Nny2EMH5QTUrktqkYm8VMRpj3YapxtqUpIZIy-wJHdxvuWI8RJPqnmEh9NKllaiRtT3Bk8-rcWT2EdnU--3x8fPIaNkPBRXXu5DWuLi8o-gZvZ18W0vNipZxKDz9fthD8B8GxdCw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Declining+Risk+of+Sudden+Death+in+Heart+Failure&rft.jtitle=The+New+England+journal+of+medicine&rft.au=Shen%2C+Li&rft.au=Jhund%2C+Pardeep+S&rft.au=Petrie%2C+Mark+C&rft.au=Claggett%2C+Brian+L&rft.date=2017-07-06&rft.pub=Massachusetts+Medical+Society&rft.issn=0028-4793&rft.eissn=1533-4406&rft.volume=377&rft.issue=1&rft.spage=41&rft.epage=51&rft_id=info:doi/10.1056%2FNEJMoa1609758&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-4793&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-4793&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-4793&client=summon |